Pharmacy spend is becoming a key value lever at US portfolio companies as PE firms up their focus on healthcare oversight, ...

CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a ...

STEERLife and Callidus Research Laboratories have forged a strategic partnership to accelerate drug development for global markets.

Amazon, DHL, GXO, Kuehne+Nagel, Pepsico and True Value Co. are among firms announcing job cuts, according to a new round of ...

If a software product is successful enough, you'll probably be able to find a company building an open source alternative.

There isn’t a Hollywood director with a sense of scale, scope, and range quite like Ridley Scott. For five decades and ...

AstraZeneca’s AZN third-quarter 2024 core earnings of $1.04 per American depositary share (ADS) beat the Zacks Consensus ...

Organon reported solid Q3 2024 results with 4% revenue growth, driven by strong volume growth. Check out why I upgraded OGN ...

U.S. FDA approved Emrosi (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of 2025 Tot ...

AAA fails to conjure any of the magic Erivo brings to her new fantasy film with Ariana Grande. Instead, the record is an ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.